UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

The ephrin receptor tyrosine kinase A2 is a cellular receptor for Kaposi's sarcoma–associated herpesvirus

Nature medicine, 2012-06, Vol.18 (6), p.961-966

2012

Volltextzugriff (PDF)

Artificial riboswitches for gene expression and replication control of DNA and RNA viruses

Proceedings of the National Academy of Sciences - PNAS, 2014-02, Vol.111 (5), p.1674-1674

2014

Volltextzugriff (PDF)

Histone deacetylase 6 inhibition enhances oncolytic viral replication in glioma

The Journal of clinical investigation, 2015-11, Vol.125 (11), p.4269-4280

2015

Volltextzugriff (PDF)

Preclinical investigation of combined gene-mediated cytotoxic immunotherapy and immune checkpoint blockade in glioblastoma

Neuro-oncology (Charlottesville, Va.), 2018-01, Vol.20 (2), p.225-235

2018

Volltextzugriff (PDF)

The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma Cells

PloS one, 2015-05, Vol.10 (5), p.e0127058-e0127058

2015

Volltextzugriff (PDF)

Retargeting of Rat Parvovirus H-1PV to Cancer Cells through Genetic Engineering of the Viral Capsid

Journal of Virology, 2012-04, Vol.86 (7), p.3452-3465

2012

Volltextzugriff (PDF)

Adenoviruses using the cancer marker EphA2 as a receptor in vitro and in vivo by genetic ligand insertion into different capsid scaffolds

PloS one, 2014-04, Vol.9 (4), p.e95723-e95723

2014

Volltextzugriff (PDF)

CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy

Molecular therapy, 2014-11, Vol.22 (11), p.1949-1959

2014

Volltextzugriff (PDF)

Generation of an Adenovirus-Parvovirus Chimera with Enhanced Oncolytic Potential

Journal of Virology, 2012-10, Vol.86 (19), p.10418-10431

2012

Volltextzugriff (PDF)

Replication and virus-induced transcriptome of HAdV-5 in normal host cells versus cancer cells--differences of relevance for adenoviral oncolysis

PloS one, 2011-11, Vol.6 (11), p.e27934-e27934

2011

Volltextzugriff (PDF)

Glioma virus therapies between bench and bedside

Neuro-oncology (Charlottesville, Va.), 2014-03, Vol.16 (3), p.334-351

2014

Volltextzugriff (PDF)

Virus chimeras for gene therapy, vaccination, and oncolysis: adenoviruses and beyond

Trends in molecular medicine, 2012-07, Vol.18 (7), p.365-376

2012

Volltextzugriff (PDF)

Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM‐CSF: Results in vitro, in rodents and in humans

International journal of cancer, 2015-10, Vol.137 (7), p.1775-1783

2015

Volltextzugriff (PDF)

Improving Cancer Immunotherapies through Empirical Neoantigen Selection

Trends in cancer, 2018-02, Vol.4 (2), p.97-100

2018

Volltextzugriff (PDF)

1100 Immunovirotherapy with the codon-modified influenza virus CodaLytic™ modulates the quality of the tumor immune infiltrate in support of anti-tumor immunity

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1211-A1211

2023

Volltextzugriff (PDF)

Chemovirotherapy of Malignant Melanoma with a Targeted and Armed Oncolytic Measles Virus

Journal of investigative dermatology, 2013-04, Vol.133 (4), p.1034-1042

2013

Volltextzugriff (PDF)

Genetic delivery of an immunoRNase by an oncolytic adenovirus enhances anticancer activity

International journal of cancer, 2015-05, Vol.136 (9), p.2228-2240

2015

Volltextzugriff (PDF)

Oncolytic virotherapy for gliomas: steps toward the future

CNS oncology, 2013-09, Vol.2 (5), p.389-392

2013

Volltextzugriff (PDF)

Immunological profiling of tumor-infiltrating CD8+ T lymphocytes in non-small cell lung cancer, head and neck squamous cell carcinoma, breast cancer, and renal cell cancer

The Journal of immunology (1950), 2022-05, Vol.208 (1_Supplement), p.179-179.10

2022

Volltextzugriff (PDF)

Response to anti-PD-1 and anti-LAG-3 immune checkpoint blockade (ICB) is associated with induction of pro-inflammatory Tregs

The Journal of immunology (1950), 2020-05, Vol.204 (1_Supplement), p.91-91.18

2020

Volltextzugriff (PDF)

Abstract 3242: Triple checkpoint blockade targeting PD-1, TIM-3, and LAG-3 reinvigorates ovarian cancer-infiltrating T cells by increasing T cell polyfunctionality and effector function

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.3242-3242

2019

Volltextzugriff (PDF)

1938. CoviLiv™, a Novel Intranasal Live-Attenuated COVID-19 Vaccine Candidate, Induces Robust Humoral and Cellular Immunity in First-In-Human Clinical Trial CDX-CoV-001

Open forum infectious diseases, 2023-11, Vol.10 (Supplement_2)

2023

Volltextzugriff (PDF)

Abstract 2706: Comprehensive immune profiling of primary tumor-infiltrating lymphocytes isolated from primary non-small cell lung cancer specimens

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.2706-2706

2019

Volltextzugriff (PDF)

Abstract 689: The codon-modified influenza virus CodaLytic™rescues immunostimulatory activity and anti-tumor efficacy in PD-1-refractory tumor models

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.689-689

2023

Volltextzugriff (PDF)

Abstract PD2-04: Preclinical development of CodaLytic™, a codon-modified influenza virus, as a novel virotherapeutic agent for breast cancer immunotherapy

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.PD2-04-PD2-04

2023

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(47)
Buchkapitel
(2)

Sprache

Englisch
(49)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The ephrin receptor tyrosine kinase A2 is a cellular receptor for Kaposi's sarcoma–associated herpesvirus

Artificial riboswitches for gene expression and replication control of DNA and RNA viruses

Histone deacetylase 6 inhibition enhances oncolytic viral replication in glioma

Preclinical investigation of combined gene-mediated cytotoxic immunotherapy and immune checkpoint blockade in glioblastoma

The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma Cells

Retargeting of Rat Parvovirus H-1PV to Cancer Cells through Genetic Engineering of the Viral Capsid

Adenoviruses using the cancer marker EphA2 as a receptor in vitro and in vivo by genetic ligand insertion into different capsid scaffolds

CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy

Generation of an Adenovirus-Parvovirus Chimera with Enhanced Oncolytic Potential

Replication and virus-induced transcriptome of HAdV-5 in normal host cells versus cancer cells--differences of relevance for adenoviral oncolysis

Glioma virus therapies between bench and bedside

Virus chimeras for gene therapy, vaccination, and oncolysis: adenoviruses and beyond

Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM‐CSF: Results in vitro, in rodents and in humans

Improving Cancer Immunotherapies through Empirical Neoantigen Selection

1100 Immunovirotherapy with the codon-modified influenza virus CodaLytic™ modulates the quality of the tumor immune infiltrate in support of anti-tumor immunity

Chemovirotherapy of Malignant Melanoma with a Targeted and Armed Oncolytic Measles Virus

Genetic delivery of an immunoRNase by an oncolytic adenovirus enhances anticancer activity

Oncolytic virotherapy for gliomas: steps toward the future

Immunological profiling of tumor-infiltrating CD8+ T lymphocytes in non-small cell lung cancer, head and neck squamous cell carcinoma, breast cancer, and renal cell cancer

Response to anti-PD-1 and anti-LAG-3 immune checkpoint blockade (ICB) is associated with induction of pro-inflammatory Tregs

Abstract 3242: Triple checkpoint blockade targeting PD-1, TIM-3, and LAG-3 reinvigorates ovarian cancer-infiltrating T cells by increasing T cell polyfunctionality and effector function

1938. CoviLiv™, a Novel Intranasal Live-Attenuated COVID-19 Vaccine Candidate, Induces Robust Humoral and Cellular Immunity in First-In-Human Clinical Trial CDX-CoV-001

Abstract 2706: Comprehensive immune profiling of primary tumor-infiltrating lymphocytes isolated from primary non-small cell lung cancer specimens

Abstract 689: The codon-modified influenza virus CodaLytic™rescues immunostimulatory activity and anti-tumor efficacy in PD-1-refractory tumor models

Abstract PD2-04: Preclinical development of CodaLytic™, a codon-modified influenza virus, as a novel virotherapeutic agent for breast cancer immunotherapy

Suchergebnisse filtern